ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free ZVSA Stock Alerts $4.99 -1.08 (-17.79%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ZyVersa Therapeutics Stock Price Performance5 Day Performance-13.19%1 Month Performance-35.82%3 Month Performance-24.47%6 Month Performance-87.04%Year-To-Date Performance-44.56%1 Year Performance-97.16% Receive ZVSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ZVSA Stock Chart for Saturday, April, 27, 2024 ZVSA Chart by TradingView ZyVersa Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$6.08$4.99-17.86%$6.20$4.44439,563 shs$37.82 million04/25/2024$6.10$6.08-0.41%$6.30$5.6039,656 shs$4.61 million04/24/2024$5.72$6.10+6.64%$6.20$5.7432,864 shs$4.62 million04/23/2024$5.75$5.72-0.49%$5.85$5.5015,457 shs$4.34 million04/22/2024$5.86$5.75-1.91%$6.04$5.5024,136 shs$4.36 million04/19/2024$6.26$5.86-6.39%$6.40$5.7128,422 shs$4.44 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$5.83$6.26+7.47%$6.42$5.8342,202 shs$4.75 million04/17/2024$5.78$5.83+0.85%$6.00$5.6021,176 shs$4.42 million04/16/2024$6.36$5.78-9.11%$6.30$5.7032,927 shs$4.38 million04/15/2024$7.10$6.36-10.49%$7.30$6.3046,109 shs$4.82 million04/12/2024$7.50$7.10-5.33%$7.60$7.0035,659 shs$5.38 million04/11/2024$7.50$7.50$8.05$7.2037,224 shs$5.69 million04/10/2024$7.18$7.50+4.49%$7.50$7.0320,367 shs$5.69 million04/09/2024$7.33$7.18-2.05%$7.36$7.159,057 shs$5.44 million04/08/2024$7.34$7.33-0.11%$7.66$7.2019,113 shs$5.56 million04/05/2024$7.40$7.34-0.92%$7.46$7.2029,511 shs$5.56 million04/04/2024$7.13$7.40+3.92%$7.86$7.20111,254 shs$5.61 million04/03/2024$7.29$7.13-2.26%$7.50$6.9312,803 shs$5.40 million04/02/2024$7.43$7.29-1.88%$7.47$6.8116,410 shs$5.53 million04/01/2024$7.50$7.43-0.93%$7.65$7.2018,879 shs$5.63 million03/29/2024$7.50$7.50$8.40$7.4087,173 shs$5.69 million03/28/2024$7.78$7.50-3.54%$8.40$7.4086,534 shs$5.69 million03/27/2024$7.49$7.78+3.79%$7.82$7.1640,369 shs$5.89 million03/26/2024$8.00$7.49-6.36%$8.00$7.0944,762 shs$5.68 million03/25/2024$8.16$8.00-1.96%$8.17$7.8032,577 shs$6.06 million03/22/2024$8.20$8.16-0.49%$8.30$7.9023,917 shs$6.19 million03/21/2024$8.42$8.20-2.66%$8.56$8.0037,939 shs$6.22 million03/20/2024$8.11$8.42+3.87%$8.71$7.9031,051 shs$6.39 million03/19/2024$8.49$8.11-4.49%$8.50$7.6064,287 shs$6.15 million03/18/2024$7.81$8.49+8.79%$10.20$8.00705,359 shs$6.44 million03/15/2024$7.99$7.81-2.30%$8.34$7.8142,065 shs$5.92 million03/14/2024$7.81$7.99+2.29%$8.20$7.9038,744 shs$6.06 million03/13/2024$7.89$7.81-1.03%$8.20$7.5036,723 shs$5.92 million03/12/2024$8.66$7.89-8.87%$8.90$7.8047,759 shs$5.98 million03/11/2024$9.49$8.66-8.80%$9.73$8.20105,299 shs$6.56 million03/08/2024$9.55$9.49-0.57%$10.60$9.2081,810 shs$1.18 million03/07/2024$7.69$9.55+24.18%$10.80$7.60344,904 shs$1.18 million03/06/2024$8.60$7.69-10.59%$8.84$7.5070,975 shs$953,000.0003/05/2024$9.60$8.60-10.37%$9.10$8.3092,791 shs$1.07 million03/04/2024$10.40$9.60-7.74%$10.30$9.02108,470 shs$1.19 millionProtect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself03/01/2024$11.00$10.40-5.45%$11.80$10.20134,504 shs$1.29 million02/29/2024$10.00$11.00+10.00%$12.00$9.62391,632 shs$1.36 million02/28/2024$10.90$10.00-8.26%$12.40$9.31542,618 shs$1.24 million02/27/2024$10.80$10.90+0.93%$13.40$10.401.19 million shs$1.35 million02/26/2024$8.01$10.80+34.83%$25.00$10.408.87 million shs$1.34 million02/23/2024$6.20$8.01+29.13%$8.38$5.80715,935 shs$993,000.0002/22/2024$6.10$6.20+1.69%$7.28$6.10178,163 shs$769,000.0002/21/2024$5.97$6.10+2.25%$8.40$5.73392,608 shs$756,000.0002/20/2024$5.90$5.97+1.14%$6.20$5.8026,102 shs$743,000.0002/19/2024$5.90$5.90$6.20$5.8018,490 shs$731,000.0002/16/2024$5.77$5.90+2.22%$6.20$5.8018,485 shs$731,000.0002/15/2024$5.79$5.77-0.31%$6.20$5.6513,379 shs$718,000.0002/14/2024$5.55$5.79+4.25%$5.95$5.6012,231 shs$717,000.0002/13/2024$5.72$5.55-2.99%$5.80$5.5510,019 shs$688,000.0002/12/2024$5.84$5.72-1.99%$5.94$5.6314,793 shs$709,000.0002/09/2024$5.83$5.84+0.07%$6.10$5.727,787 shs$724,000.0002/08/2024$6.00$5.83-2.78%$6.00$5.4045,091 shs$723,000.0002/07/2024$6.05$6.00-0.83%$6.10$5.7618,629 shs$744,000.0002/06/2024$6.10$6.05-0.75%$6.20$5.5029,037 shs$750,000.0002/05/2024$5.84$6.10+4.35%$6.30$5.8314,428 shs$759,000.0002/02/2024$5.85$5.84-0.20%$6.25$5.8010,257 shs$724,000.0002/01/2024$5.70$5.85+2.68%$6.47$5.808,217 shs$726,000.0001/31/2024$6.32$5.70-9.79%$6.37$5.5075,516 shs$707,000.0001/30/2024$6.40$6.32-1.25%$6.55$6.0014,728 shs$784,000.0001/29/2024$6.61$6.40-3.13%$6.70$5.8030,027 shs$794,000.0001/26/2024$6.62$6.55-0.97%$6.90$6.4321,025 shs$813,000.00 Related Companies: LIPO Stock Price Chart CING Stock Price Chart GNPX Stock Price Chart ARTL Stock Price Chart THAR Stock Price Chart SNGX Stock Price Chart SEEL Stock Price Chart ENSC Stock Price Chart CPHI Stock Price Chart LGVN Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.